Texas Compliance Controlled Substance Continuing Ed
CE Programs
The Texas Opioid Training Initiative provides 10+ hours of free online continuing education for a broad range of health professionals, including physicians, pharmacists, nurses, and social workers.
Texas Perspective: Public Health and Evidence-Based Approach for Improving the Substance Use Treatment Ecosystem
Crystal Walker, DMSc, PA-C
Director of Substance Use Disorders Clinical Services
MHMR of Tarrant County
Launch
Innovation and Reform in Substance Use, Law Enforcement, and Policing
Brandon del Pozo, PhD, MPA, MA
Postdoctoral Fellow, Miriam Hospital, Warren Alpert Medical School of Brown University
Associate Faculty, Department of Health Policy and Management, Johns Hopkins Blumberg School of Public Affairs
Research Fellow, Global Law Enforcement and Public Health Association, & Executive Fellow, National Police Foundation
Launch
Creating Supportive Treatment Environments for BIPOC, Tailoring Treatment to the Realities of Substance Use at the Border
Julia Lechuga, MA, PhD
Associate Professor of Public Health
The University of Texas at El Paso College of Health Sciences
Launch
From Survival to Recovery in Opioid Use Disorder
This program describes the best practices for opioid overdose prevention, compares the FDA-approved medications for opioid use disorder and discusses current controversies and ethical issues in opioid use disorder treatment.
Launch
Harm Reduction Basics for Healthcare Professionals
In this program, you will learn about the fundamentals of harm reduction, the historical and modern-day context surrounding drug use in the United States and examine the three waves of the opioid crisis.
Launch
Developing and Implementing an Opioid Stewardship Program
This program describes the development, implementation, and evaluation of an opioid stewardship program in a large academic health center. It identifies strategies to improve safe opioid use within health systems and discusses the development of collaborative strategies with state and local entities to improve opioid use throughout a community.
Launch
Non-Opioid Alternatives for Pain Management in the Hospital Setting
In this program, instructors describe the role of various non-opioid analgesics in hospital-based pain management, and discuss how to implement pain management strategies that incorporate both non-opioid and opioid analgesics.
Launch
The B-Team: An Innovative Model for Inpatient Treatment Initiation
This program describes the development and implementation of an OUD treatment service led by internal medicine clinicians in collaboration with a broad range of interprofessional team members. It will help you plan to develop or expand similar services at your institution by engaging an interprofessional team.
Launch
Managing Medications for Opioid Use Disorder During Hospitalization
This program discusses case examples to demystify the management of FDA-approved medications for opioid use disorder in various inpatient treatment scenarios. It also identifies strategies to effectively navigate pain management, peri-operative care and other potentially complex situations.
Launch
From Survival to Recovery in Opioid Use Disorder
This program describes the best practices for opioid overdose prevention, compares the FDA-approved medications for opioid use disorder and discusses current controversies and ethical issues in opioid use disorder treatment.
Launch
Harm Reduction Basics for Healthcare Professionals
This program describes the fundamentals of harm reduction, discusses the historical and modern-day context surrounding drug use in the United States and compares the three waves of the opioid crisis.
Launch
Pain, Opioids, and Choices: When Tapering and Safety Collide
Examine policy steps that healthcare and related systems have taken to pivot away from prescription opioids and the effect it is having on patients, families, clinicians and pharmacists. This program reviews the full history of peripheral, central and contextual pain drivers when assessing chronic pain in patients, the evidence that explains whether opioids are effective in managing long-term chronic pain and discusses whether opioid reduction and discontinuation under regular practice conditions is followed by safety improvement.
Launch
Effective Use of the Prescription Monitoring Program
In this program, you will learn about the impact of mandated prescription monitoring program (PMP) use, the debates surrounding pain management in the age of PMPs and monitoring of morphine milligram equivalents (MMEs) and the use of non-stigmatizing and inclusive language with patients to address common situations around controlled substances.
Launch
STANDALONE COURSES
Acute Pain Management in Patients with OUD
This Opioid Training Initiative course was developed to prepare healthcare professionals who work to manage pain for patients in the hospital setting with opioid use disorder (OUD). The course supports development of an approach to manage pain with hospitalized individuals with OUD, and compare pain management strategies for individuals with OUD taking buprenorphine, methadone, extended release naltrexone, and non-prescribed opioids. The course also reviews considerations for transition of care and discharge planning.
Launch
Buprenorphine-Naloxone versus Extended-Release Naltrexone: A Comparison of Efficacy and Safety
This Opioid Training Initiative course was developed to prepare healthcare professionals who work with clients with opioid use disorder. Through the course, participants will be able to describe the neurobiological processes involved in OUD, evaluate the efficacy and safety of two medications for OUD (MOUD) and analyze existing evidence for optimal MOUD selection.
Launch
Effective Communication Strategies with Patients in the Hospital Setting with Opioid Use Disorder
This Opioid Training Initiative course was developed to prepare healthcare professionals who work with opioid use disorder (OUD) patients. Through this course, Dr. Berg discusses common engagement challenges with patients in the hospital setting with OUD and discusses use of the Prescription Monitoring Program (PMP) to facilitate constructive harm reduction conversations. He also identifies evidence-based communication strategies to enhance engagement and decrease discord in addressing opiate misuse. The focus of this program is on patient communication where evidence has shown to be one of the major factors in success in recovery.
Launch
Overview of B Team, Implementation Barriers, and Grow Strategies
This Opioid Training Initiative course was developed to prepare healthcare professionals who work with patients with opioid use disorder (OUD). Through this course, Dr. Mason and Dr. Janzen describe the development and basic components of a buprenorphine program in an acute care hospital setting while also describing the effectiveness of interprofessional collaborations for patient care. Further, they describe evidence-based best practices in treatment of OUD during acute hospitalization.
Launch
Opioid Neonatal Abstinence Syndrome
This program discusses the best practices for the care of women with opioid use disorder, describes neonatal abstinence syndrome (NAS) and evidence-based management strategies and reviews a community-driven, harm reduction approach to the care of opioid-impacted women and children.
Launch
Opioid Overdose Prevention and Response
This program conveys foundational knowledge regarding the triple wave opioid crisis, identification of patients at risk for opioid overdose and key elements of patient education regarding naloxone. It also includes a detailed discussion of laws and regulations impacting naloxone distribution, as well as a comparison of the four naloxone formulations which are appropriate for layperson use.
Launch
Role of Stigma in Opioid Use Disorder
This Opioid Training Initiative course was developed for healthcare practitioners who work with individuals with opioid use disorder and other substance use disorders. The goal of this course is to help the practitioner define stigma and its historical origins Identify different types of stigma and discuss how stigma decreases access to care for people with substance use disorders. Stigma and the personal experience of patients who are subject to stigma language from healthcare professionals is a major obstacle in their treatment. Understanding the impact of stigma including body language, interpersonal communication and environmental factors pay a major role in treatment results.
Launch
Source: https://txoti.org/ce-programs
0 Response to "Texas Compliance Controlled Substance Continuing Ed"
Post a Comment